Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DNA-based typing of blood groups for the management of multiply-transfused sickle cell disease patients.

Transfusion - 1 Feb 2002

Castilho Lilian, Rios Maria, Bianco Celso, Pellegrino Jordão, Alberto Fernando L, Saad Sara T O, Costa Fernando F

Abstract excerpt

BACKGROUND: The usefulness of DNA genotyping for RBC antigens as a tool for the management of multiply-transfused patients with sickle cell disease (SCD) to overcome the limitations of hemagglutination assays was evaluated. STUDY DESIGN AND METHODS: Blood samples from 40 multiply-transfused SCD p...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anemia, Sickle Cell
Share to Blood Group Antigens
Share to Blood Grouping and Crossmatching

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Transfusion

Share to Duffy Blood-Group System

Share to Hemagglutination

Share to Kell Blood-Group System

Share to Rh-Hr Blood-Group System

Source

Identifiers

PMID: 11896340
DOI: 10.1046/j.1537-2995.2002.00029.x

Genes

SCD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-11896340-2026-09-04.1. Manifest publication-graph-cohort-2026-09-04.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DNA-based typing of blood groups for the management of multiply-transfused sickle cell disease patients.PMID 11896340Read ↗

Changing practice: red blood cell typing by molecular methods for patients with sickle cell diseaseSemantic proximity Read ↗

Blood group genotyping in multi-transfused patients.Semantic proximity Read ↗

Differentiation of autologous ABO, RHD, RHCE, KEL, JK, and FY blood group genotypes by analysis of peripheral blood samples of patients who have recently received multiple transfusions.Semantic proximity Read ↗

Blood group genotyping facilitates transfusion of beta-thalassemia patients.Semantic proximity Read ↗

DNA from blood samples can be used to genotype patients who have recently received a transfusion.Semantic proximity Read ↗

Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease.Semantic proximity Read ↗

Importance of extended blood group genotyping in multiply transfused patients.Semantic proximity Read ↗

Benefits of blood group genotyping in multi-transfused patients from the south of Brazil.Semantic proximity Read ↗

Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk.Semantic proximity Read ↗

Molecular genotyping of clinically important blood group antigens in patients with thalassaemiaSemantic proximity Read ↗

Blood group genotyping in alloimmunized multi-transfused thalassemia patients from Iran.Semantic proximity Read ↗

Molecular blood typing augments serologic testing and allows for enhanced matching of red blood cells for transfusion in patients with sickle cell diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.